October 28, 2016 12:10 AM ET


Company Overview of Glaxosmithkline Biologicals S.A.

Company Overview

Glaxosmithkline Biologicals S.A. researches, develops, manufactures, and supplies vaccines. Its vaccination products are used to tackle various diseases, such as rabies, diphtheria, tetanus, and yellow fever, as well as polio, measles, mumps, and rubella and hepatitis B. It has a strategic alliance VBI Vaccines Inc. GlaxoSmithKline Biologicals S.A. with was formerly known as SmithKline Beecham Biologicals S.A. and changed its name to GlaxoSmithKline Biologicals S.A. in 2000. The company was founded in 1945 and is based in Rixensart, Belgium. Glaxosmithkline Biologicals S.A. operates as a subsidiary of GlaxoSmithKline plc.

Rue de l'institut 89

Rixensart,  1330


Founded in 1945


32 2 656 81 11


32 2 656 80 00

Key Executives for Glaxosmithkline Biologicals S.A.

Chief Executive of GlaxoSmithKline PLC
Age: 51
Compensation as of Fiscal Year 2016.

Glaxosmithkline Biologicals S.A. Key Developments

VBI Vaccines Announces Research Collaboration with GlaxoSmithKline to Enhance Vaccine Stability

VBI Vaccines Inc. has entered into a research collaboration with GlaxoSmithKline Biologicals SA to evaluate VBI’s LPV™ Platform. VBI’s LPV Platform is a proprietary formulation and process that enables the development of vaccines and biologics with improved stability and preserved potency. Under the terms of the research collaboration, GSK has the option to negotiate an exclusive license to VBI’s LPV Platform for use in a defined field. Further terms of the collaboration were not disclosed. Stability is a critical issue potentially affecting vaccine potency, safety, and ultimately patient access. The LPV Platform uses a proprietary formulation and process to enclose and protect the antigen (active component) of a vaccine or biologic. VBI has completed proof of concept studies on a number of vaccine and biologic targets that demonstrate the LPV Platform’s ability to preserve potency under stress conditions.

GSK Vaccines Presents at BIO-Europe 2015, Nov-02-2015

GSK Vaccines Presents at BIO-Europe 2015, Nov-02-2015 . Venue: Munich, Germany.

GSK Vaccines Presents at BIO-Europe Spring 2015, Mar-09-2015

GSK Vaccines Presents at BIO-Europe Spring 2015, Mar-09-2015 . Venue: Paris Expo - Porte de Versailles, Hall 5, Paris, France.

Similar Private Companies By Industry

Company Name Region
Amakem NV Europe
Aminolabs SA Europe
Apotheek Delestre NV Europe
Apotheek Moons NV Europe
Apotheek Philips NV Europe

Recent Private Companies Transactions

No transactions available in the past 12 months.

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Bertelsmann AG Europe
Rush University United States
Bloomberg L.P. United States

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Glaxosmithkline Biologicals S.A., please visit --. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.